Skip to content Skip to footer
Subscribe Now
Biopharma M&A Top 20 2024
TOP 20

Top 20 Biopharma M&A of 2024 by Total Deal Value

Top 20 Biopharma M&A of 2024 by Total Deal ValueShots:Dealmaking in 2024 experienced fluctuations due to regulatory challenges and increasing pressure from the Inflation Reduction ActThe highest-value deal of the year was Vertex’s acquisition of Alpine Immune Sciences for $4.9B, followed by Gilead’s acquisition of CymaBay for $4.3B and Lilly’s acquisition of…
February 6, 2025

Read more

Insights+: The US FDA New Drug Approvals in 2018
INSIGHTS+

Insights+: The US FDA New Drug Approvals in 2018

1. Janssen's Erleada (apalutamide) Receives FDA Approval for Non-Metastatic Castration-Resistant Prostate Cancer (NM-CRPC)Published: 14 Feb,2018 | Tags: Janssen, Erleada, apalutamide, Receives, FDA, Approval, Non-Metastatic Castration-Resistant Prostate Cancer, NM-CRPC2. Helsinn's (fosnetupitant + palonosetron) Receives FDA Approval for Managing Chemotherapy-Induced Nausea and Vomiting (CINV)Published: 14 Feb,2018 | Tags: Helsins, fosnetupitant + palonosetron, Receives, FDA, Approval, Managing Chemotherapy-Induced Nausea and Vomiting,…
March 4, 2019

Read more

PharmaShots Year in Review: Biosimilars Approvals in 2018
INSIGHTS+

PharmaShots Year in Review: Biosimilars Approvals in 2018

THE US FDA APPROVALS 1.  Pfizer's Retacrit (epoetin alfa-epbx, biosimilar) Receives FDA Approval for AnemiaPublished: 15 May, 2018  | Tags: Pfizer, Retacrit, epoetinalfa-epbx, biosimilar, Receives, FDA, Approval, Anemia2.   Pfizer's Nivestym (filgrastim-aafi, biosmilar) Receives FDA Approval for Neutropenia  Published: 20 Jul, 2018 | Tags: (filgrastim-aafi approval biosmilar), Neutropenia, Nivestym, Pfizer, Receives, the US FDA3.  Sandoz's Hymiroz (adalimumab-adaz, biosimilar) Receives the US FDA…
January 8, 2019

Read more

PharmaShots' Most Read News of 2018
INSIGHTS+

PharmaShots’ Most Read News of 2018

PharmaShots' Most Read News of 2018 | Top 10 Pharma News of 2018 1. Celgene to Acquire Juno for its Cellular Immunotherapy & Hematology PortfolioPublished: 22 Jan, 2018 | Tags: Celgene,  Acquire, Juno, Cellular, Immunotherapy, Hematology Portfolio2.  Sanofi to Acquire Bioverativ for its Hemophilia ProductsPublished: 22 Jan, 2018 | Tags: Sanofi, Acquire, Bioverativ, Treat,…
January 2, 2019

Read more